Neurologic complications of influenza B virus infection in adults, Romania

Emerging Infectious Diseases

Volumn 23, Issue 4, 2017, Pages 574-581

  Popescu, Corneliu P ^a,b,c   Florescu, Simin A ^a,b   Lupulescu, Emilia ^a,d   Zaharia, Mihaela ^b,c   Tardei, Gratiela ^b   Lazar, Mihaela ^d   Ceausu, Emanoil ^b   Ruta, Simona M ^a,e  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^c European Society for Clinical Microbiology and Infectious Diseases   (Switzerland)

^d Development for Microbiology and Immunology   (Romania)

^e STEFAN S NICOLAU INSTITUTE OF VIROLOGY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALBUMIN; CORTICOSTEROID; MANNITOL; MEROPENEM; METHYLPREDNISOLONE; OSELTAMIVIR; THIAMAZOLE;

ADULT; AGITATION; APHASIA; ARTICLE; ARTIFICIAL VENTILATION; BALANCE DISORDER; CEREBELLAR ATAXIA; CEREBROSPINAL FLUID ANALYSIS; CHILL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIFFUSION WEIGHTED IMAGING; DYSARTHRIA; FEMALE; FEVER; GLASGOW COMA SCALE; HEADACHE; HEART VENTRICLE TACHYCARDIA; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HYPERTHYROIDISM; INFLUENZA B; INFLUENZA B VIRUS; INTUBATION; KIDNEY FAILURE; LUMBAR PUNCTURE; MALE; MIDDLE AGED; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; MYALGIA; MYDRIASIS; NEUROLOGICAL COMPLICATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; PHOTOPHOBIA; PHYLOGENY; PLEOCYTOSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINORRHEA; SEIZURE; SILVER RUSSELL SYNDROME; SOMNOLENCE; VERTIGO; VIRUS ENCEPHALITIS; VIRUS ISOLATION; VOMITING; YOUNG ADULT; ADOLESCENT; AGED; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; COMPLICATION; INFLUENZA; MORTALITY; ROMANIA; VERY ELDERLY; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; FEMALE; HUMANS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROMANIA; YOUNG ADULT;

EID: 85015764786     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2304.161317     Document Type: Article

References (41)

1. Studahl M. Influenza virus and CNS manifestations. J Clin Virol. 2003;28:225-32. http://dx.doi.org/10.1016/S1386-6532(03)00119-7
2. Ekstrand JJ. Neurologic complications of influenza. Semin Pediatr Neurol. 2012;19:96-100. http://dx.doi.org/10.1016/j.spen.2012.02.004
3. Ravenholt RT, Foege WH. 1918 influenza, encephalitis lethargica, parkinsonism. Lancet. 1982;2:860-4. http://dx.doi.org/10.1016/S0140-6736(82)90820-0
4. McCullers JA, Facchini S, Chesney PJ, Webster RG. Influenza B virus encephalitis. Clin Infect Dis. 1999;28:898-900. http://dx.doi.org/10.1086/515214
5. Newland JG, Laurich VM, Rosenquist AW, Heydon K, Licht DJ, Keren R, et al. Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. J Pediatr. 2007;150:306-10. http://dx.doi.org/10.1016/j.jpeds.2006.11.054
6. Sazgar M, Robinson JL, Chan AK, Sinclair DB. Influenza B acute necrotizing encephalopathy: a case report and literature review. Pediatr Neurol. 2003;28:396-9. http://dx.doi.org/10.1016/S0887-8994(03)00008-0
7. Newland JG, Romero JR, Varman M, Drake C, Holst A, Safranek T, et al. Encephalitis associated with influenza B virus infection in 2 children and a review of the literature. Clin Infect Dis. 2003;36:e87-95. http://dx.doi.org/10.1086/368184
8. Francis T Jr. A new type of virus from epidemic influenza. Science. 1940;92:405-8. http://dx.doi.org/10.1126/science.92.2392.405
9. Chen R, Holmes EC. The evolutionary dynamics of human influenza B virus. J Mol Evol. 2008;66:655-63. http://dx.doi.org/10.1007/s00239-008-9119-z
10. McCullers JA, Hayden FG, Fatal Influenza B. Fatal influenza B infections: time to reexamine influenza research priorities. J Infect Dis. 2012;205:870-2. http://dx.doi.org/10.1093/infdis/jir865
11. Leigh AD. Infections of the nervous system occurring during an epidemic of influenza B. BMJ. 1946;2:936-8. http://dx.doi.org/10.1136/bmj.2.4485.936
12. National Center for Infectious Diseases Control. Analyses of trends of communicable diseases under surveillance, 2014 [in Romanian] [cited 2016 Sep 9]. http://www.cnscbt.ro/index.php/rapoarte-anuale/548-analiza-evolutiei-bolilor-transmisibile-aflate-in-supraveghere-raport-pentru-anul-2014/file
13. Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos KL, et al.; Infectious Diseases Society of America. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47:303-27. http://dx.doi.org/10.1086/589747
14. Cherciu CM, Necula G, Mihai ME, Ivanciuc AE, Lazăr M, Ţecu C, et al. Differentiation of influenza B lineages from clinical samples by one-step real-time RT-PCR. Roum Arch Microbiol Immunol. 2014;73:25-9.
15. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 2014;30:1312-3. http://dx.doi.org/10.1093/bioinformatics/btu033
16. Morishima T, Togashi T, Yokota S, Okuno Y, Miyazaki C, Tashiro M, et al.; Collaborative Study Group on Influenza-Associated Encephalopathy in Japan. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis. 2002;35:512-7. http://dx.doi.org/10.1086/341407
17. Goenka A, Michael BD, Ledger E, Hart IJ, Absoud M, Chow G, et al. Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance Study. Clin Infect Dis. 2014;58:775-84. http://dx.doi.org/10.1093/cid/cit922
18. Lin CH, Huang YC, Chiu CH, Huang CG, Tsao KC, Lin TY. Neurologic manifestations in children with influenza B virus infection. Pediatr Infect Dis J. 2006;25:1081-3. http://dx.doi.org/10.1097/01.inf.0000243194.80616.a9
19. Vianello FA, Osnaghi S, Laicini EA, Milani GP, Tardini G, Cappellari AM, et al. Optic neuritis associated with influenza B virus meningoencephalitis. J Clin Virol. 2014;61:463-5. http://dx.doi.org/10.1016/j.jcv.2014.09.010
20. Samanta D. Influenza B-associated acute necrotizing encephalopathy of childhood: a report from North America. Acta Neurol Belg. 2016;116:383-5. http://dx.doi.org/10.1007/s13760-015-0573-2
21. Ak Ö, Biteker F, Cag Y, Öcal G, Benzonana N, Ciblak MA, et al. Influenza B-associated encephalopathy in two adults. J Infect Chemother. 2012;18:961-4. http://dx.doi.org/10.1007/s10156-012-0413-8
22. Une H, Uehara T, Tateishi T, Shigetou H, Oyagi Y, Kira J. Case of non-convulsive status epilepticus after influenza virus B infection [in Japanese]. Rinsho Shinkeigaku. 2014;54:227-30. http://dx.doi.org/10.5692/clinicalneurol.54.227
23. Centers for Disease Control and Prevention. Influenza-associated pediatric deaths—United States, September 2010-August 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1233-8.
24. Gu Y, Shimada T, Yasui Y, Tada Y, Kaku M, Okabe N. National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009-2010 influenza pandemic. PLoS One. 2013;8:e54786. http://dx.doi.org/10.1371/journal.pone.0054786
25. Wang GF, Li W, Li K. Acute encephalopathy and encephalitis caused by influenza virus infection. Curr Opin Neurol. 2010; 23:305-11. http://dx.doi.org/10.1097/WCO.0b013e328338f6c9
26. Maricich SM, Neul JL, Lotze TE, Cazacu AC, Uyeki TM, Demmler GJ, et al. Neurologic complications associated with influenza A in children during the 2003-2004 influenza season in Houston, Texas. Pediatrics. 2004;114:e626-33. http://dx.doi.org/10.1542/peds.2004-0143
27. Kawashima H, Morichi S, Okumara A, Nakagawa S, Morishima T; Collaborating Study Group on Influenza-Associated Encephalopathy in Japan. National survey of pandemic influenza A (H1N1) 2009-associated encephalopathy in Japanese children. J Med Virol. 2012;84:1151-6. http://dx.doi.org/10.1002/jmv.23317
28. Takahashi M, Yamada T, Nakashita Y, Saikusa H, Deguchi M, Kida H, et al. Influenza virus-induced encephalopathy: clinicopathologic study of an autopsied case. Pediatr Int. 2000;42:204-14. http://dx.doi.org/10.1046/j.1442-200x.2000.01203.x
29. Ichiyama T, Morishima T, Kajimoto M, Matsushige T, Matsubara T, Furukawa S. Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy. Pediatr Infect Dis J. 2007;26:542-4. http://dx.doi.org/10.1097/INF.0b013e31803994a0
30. To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis. 2010;50:850-9. http://dx.doi.org/10.1086/650581
31. Christian LM, Franco A, Iams JD, Sheridan J, Glaser R. Depressive symptoms predict exaggerated inflammatory responses to an in vivo immune challenge among pregnant women. Brain Behav Immun. 2010;24:49-53. http://dx.doi.org/10.1016/j.bbi.2009.05.055
32. Cárdenas G, Soto-Hernández JL, Díaz-Alba A, Ugalde Y, Mérida-Puga J, Rosetti M, et al. Neurological events related to influenza A (H1N1) pdm09. Influenza Other Respi Viruses. 2014;8:339-46. http://dx.doi.org/10.1111/irv.12241
33. Henry CJ, Huang Y, Wynne AM, Godbout JP. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav Immun. 2009;23:309-17. http://dx.doi.org/10.1016/j.bbi.2008.09.002
34. Davis LE, Koster F, Cawthon A. Neurologic aspects of influenza viruses. Handb Clin Neurol. 2014;123:619-45. http://dx.doi.org/10.1016/B978-0-444-53488-0.00030-4
35. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season [cited 2016 Sep 5]. http://www.who.int/influenza/vaccines/virus/recommendations/2014_15_north/en/
36. Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother. 2012;8:81-8. http://dx.doi.org/10.4161/hv.8.1.17623
37. Valenciano M, Kissling E, Reuss A, Rizzo C, Gherasim A, Horváth JK, et al. I-MOVE multicentre case-control team. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15. Euro Surveill. 2016;21:30139. http://dx.doi.org/10.2807/1560-7917.ES.2016.21.7.30139
38. Belshe RB. The need for quadrivalent vaccine against seasonal influenza. Vaccine. 2010;28(Suppl 4):D45-53. http://dx.doi.org/10.1016/j.vaccine.2010.08.028
39. Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine. 2012;30:1993-8. http://dx.doi.org/10.1016/j.vaccine.2011.12.098
40. Mosterín Höpping A, Fonville JM, Russell CA, James S, Smith DJ. Influenza B vaccine lineage selection: an optimized trivalent vaccine. Vaccine. 2016;34:1617-22. http://dx.doi.org/10.1016/j.vaccine.2016.01.042
41. Burnham AJ, Baranovich T, Govorkova EA. Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance. Antiviral Res. 2013;100:520-34. http://dx.doi.org/10.1016/j.antiviral.2013.08.023